Presidio Medical, Inc
Clinical-stage medical device company developing an ultra low frequency neuromodulation platform to treat diseases of undesired neural activity, with an initial indication for chronic nociceptive pain. Activities include preclinical research, human clinical trials, device engineering, and regulatory submissions.
Industries
N/A
Products
Implantable ultra low frequency neuromodulation system (developmental)
An implantable spinal neuromodulation system delivering ultra low frequency waveforms via epidural leads intended to reduce neuronal signaling associated with nociceptive pain; currently in clinical development.
Implantable ultra low frequency neuromodulation system (developmental)
An implantable spinal neuromodulation system delivering ultra low frequency waveforms via epidural leads intended to reduce neuronal signaling associated with nociceptive pain; currently in clinical development.
Services
Clinical research and trials
Design and conduct of preclinical studies and human clinical trials, including first-in-human studies and pivotal randomized controlled trials for implantable neuromodulation therapies.
Clinical research and trials
Design and conduct of preclinical studies and human clinical trials, including first-in-human studies and pivotal randomized controlled trials for implantable neuromodulation therapies.
Expertise Areas
- Neuromodulation research and development
- Chronic pain clinical research
- Implantable medical device engineering
- Translational neuroscience and mechanism-of-action studies
Key Technologies
- Ultra low frequency neuromodulation
- Spinal cord stimulation via epidural leads
- Computational neural modeling
- Electrochemistry for device interfaces